Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu Li has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Yancheng Song

    Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266000, People's Republic of China

    12 shared publications
  • Zhaopeng Li

    Qingdao University, Qingdao, China

    9 shared publications
  • Dong Guo

    Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266033, Shandong Province, China

    7 shared publications
  • Shuguang Liu

    Gastrointestinal Surgery Department, Dongda Hospital, Shanxian County, Shunshi East Road, Shanxian County, Heze City, Shandong Province, People's Republic of China

    6 shared publications
  • Wencong Guo

    Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, China

    6 shared publications
  • Zhao Li

    Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266000, People's Republic of China

    5 shared publications

Latest Publications

  • Open Access

    A New Nomogram for Predicting Early Weight Loss Outcomes in Patients with Obesity Following Laparoscopic Sleeve Gastrectomy

    by Wenzhi Wu, Zhao Li, Chentong Yuan, Mingyu Yang, Yi Song, Zhenying Xu, Zhaopeng Li, Yun Lu, Xiaoming Zhou, Dongsheng Wang, et al.

    Purpose Laparoscopic sleeve gastrectomy (LSG) is an effective treatment for obesity, but early weight loss outcomes vary owing to individual nutritional and metabolic differences. We developed a nomogram model to predict early weight loss after LSG, incorporating computed tomography (CT)-based body composition metrics and preoperative inflammatory-nutritional markers. Methods We retrospectively analyzed 305 patients with obesity who underwent LSG at the Affiliated Hospital of Qingdao University between January 2016 and June 2023. An external validation cohort of 105 patients from a separate institution was also included. Patients were categorized into optimal remission (%total weight loss [%TWL] ≥ 25%) and suboptimal remission (%TWL < 25%) weight loss groups one year postoperatively. Predictive variables were identified using Least Absolute Shrinkage and Selection Operator (LASSO) regression and multivariate logistic regression. A nomogram was constructed based on the significant predictors. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), calibration curves, decision curve analysis (DCA), and clinical impact curve (CIC). Results Independent predictors of suboptimal remission included BMI > 40 kg/m2, elevated total cholesterol, high neutrophil-to-lymphocyte ratio, high cortisol, low skeletal muscle index, and elevated visceral-to-subcutaneous adipose tissue area ratio. The constructed nomogram demonstrated strong predictive performance, with AUCs of 0.864 and 0.842 in the training and external validation cohorts, respectively. Calibration curves indicated excellent agreement between predicted and observed outcomes. DCA and CIC confirmed the model’s clinical utility in both cohorts. Conclusion The developed nomogram effectively predicts early weight loss outcomes after LSG, supporting targeted perioperative management and personalized nutritional interventions.


  • Open Access

    Role of Protein Lysine Acetylation in the Pathogenesis and Treatment of Obesity and Metabolic Syndrome

    by Zhaopeng Li, Yancheng Song, Zhao Li, Shuguang Liu, Song Yi, Zhuoli Zhang, Tao Yu, Yu Li

    This review aimed to highlight the known role of histone deacetylases (HDACs) and lysine acetyltransferases (KATs) in individuals with obesity, better understand the role of HDACs and KATs enzymes in obesity and related metabolic disorders. Numerous cellular activities, including DNA replication, DNA repair, cell cycle regulation, RNA splicing, signal transmission, metabolic function, protein stability, transportation, and transcriptional regulation, are influenced by lysine acetylation. Protein lysine acetylation serves several purposes, which not only contribute to the development of metabolic disorders linked to obesity but also hold promise for therapeutic approaches. The current study demonstrates that HDACs and KATs control lysine acetylation. This review details the advancements made in the study of obesity, related metabolic diseases, and protein lysine acetylation. It contributes to our understanding of the function and mechanism of protein lysine acetylation in obesity and MS and offers a fresh method for treating these diseases.


  • Open Access

    Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy

    by Huiyang Liu, Yiming Lu, Jinbao Zong, Bei Zhang, Xiaolu Li, Hongzhao Qi, Tao Yu, Yu Li

    Targeted immunotherapies make substantial strides in clinical cancer care due to their ability to counteract the tumor's capacity to suppress immune responses. Advances in biomimetic technology with minimally immunogenic and highly targeted, are addressing issues of targeted drug delivery and disrupting the tumor's immunosuppressive environment to trigger immune activation. Specifically, the use of dendritic cell (DC) membranes to coat nanoparticles ensures targeted delivery due to DC's unique ability to activate naive T cells, spotlighting their role in immunotherapy aimed at disrupting the tumor microenvironment. The potential of DC's biomimetic membrane to mediate immune activation and target tumors is gaining momentum, enhancing the effectiveness of cancer treatments in conjunction with other immune responses. This review delves into the methodologies behind crafting DC membranes and the fusion of dendritic and tumor cell membranes for encapsulating therapeutic nanoparticles. It explores their applications and recent advancements in combating cancer, offering an all-encompassing perspective on DC biomimetic nanosystems, immunotherapy driven by antigen presentation, and the collaborative efforts of drug delivery in chemotherapy and photodynamic therapies. Current evidence shows promise in augmenting combined therapeutic approaches for cancer treatment and holds translational potential for various cancer treatments in a clinical setting.


  • Open Access

    Association between operative position and postoperative nausea and vomiting in patients undergoing laparoscopic sleeve gastrectomy

    by Zhao-Peng Li, Yan-Cheng Song, Ya-Li Li, Dong Guo, Dong Chen, Yu Li

    BACKGROUND Bariatric surgery is one of the most effective ways to treat morbid obesity, and postoperative nausea and vomiting (PONV) is one of the common complications after bariatric surgery. At present, the mechanism of the high incidence of PONV after weight-loss surgery has not been clearly explained, and this study aims to investigate the effect of surgical position on PONV in patients undergoing bariatric surgery. AIM To explore the effect of the operative position during bariatric surgery on PONV. METHODS Data from obese patients, who underwent laparoscopic sleeve gastrectomy (LSG) in the authors’ hospital between June 2020 and February 2022 were divided into 2 groups and retrospectively analyzed. Multivariable logistic regression analysis and the t -test were used to study the influence of operative position on PONV. RESULTS There were 15 cases of PONV in the supine split-leg group (incidence rate, 50%) and 11 in the supine group (incidence rate, 36.7%) (P = 0.297). The mean operative duration in the supine split-leg group was 168.23 ± 46.24 minutes and 140.60 ± 32.256 minutes in the supine group (P < 0.05). Multivariate analysis revealed that operative position was not an independent risk factor for PONV (odds ratio = 1.192, 95% confidence interval: 0.376-3.778, P = 0.766). CONCLUSION Operative position during LSG may affect PONV; however, the difference in the incidence of PONV was not statistically significant. Operative position should be carefully considered for obese patients before surgery.


  • Open Access

    Probiotic consumption and hepatic steatosis: results from the NHANES 2011–2016 and Mendelian randomization study

    by Yancheng Song, Wencong Guo, Junke Wang, Shuguang Liu, Zhaopeng Li, Yu Li

    Background: Recent research showed that probiotics treatment may reduce insulin resistance, regulate lipid metabolism, raise liver enzyme levels, and ameliorate inflammation in individuals with metabolic associated fatty liver disease (MAFLD). However, the possible effects of probiotic use on the progression of hepatic steatosis (HS) have not been identified. The purpose of this study was to investigate this in a large population database.Methods: The cross-sectional research was conducted among adults with complete data on probiotic yogurt consumption and HS in the 2011–2016 National Health and Nutrition Examination Survey (NHANES). Probiotic yogurt consumption was assessed using a dietary supplement questionnaire, while HS was evaluated with HS index (HSI). To explore their relationship, weighted univariate regression analysis, subgroup analysis, and interaction analysis were conducted. To evaluate the causal association between yogurt consumption and NAFLD, mendelian randomization analysis (MR) were performed. A restricted cubic spline (RCS) was used to analyze the relationship curve between the leves of yogurt consumption and hepatic steatosis.Results: A total of 7,891 participants were included in the study represented 146.7 million non-institutionalized residents of the United States, of whom 4,322 (54.77%) were diagnosed with HS. Multivariable logistic regression showed probiotic yogurt consumption had significantly inverse relationship for HS (OR = 0.84, 95% CI: 0.72–0.97, p = 0.02) after adjusting for all covariates. Once more, the independent relationship between probiotic yogurt consumption and HS was verified by subgroup analysis and interaction analysis. The MR analysis results indicate that there is no causal relationship between yogurt consumption and NAFLD. The RCS model demonstrated a robust J-shaped link between yogurt consumption and HS, revealing a significant decrease in risk within the lower range of yogurt consumption, which attained the lowest risk close to 0.4 cup.Conclusion: According to the NHANES data, the consumption of probiotics and yogurt has a beneficial effect on HS, whereas the MR results indicated it was not related to NAFLD. The RCS analysis indicates a J-shaped relationship between yogurt consumption and HS, which may account for the inconsistency in the results. Based on these findings, we recommend that adults take half a cup of yogurt daily.


  • Open Access

    Associations between Probiotic Exposure and yogurt consumption with Hepatic Steatosis: A nationwide cross-sectional study

    by Yancheng Song, Wencong Guo, Junke Wang, Shuguang Liu, Zhaopeng Li, Zhao Li, Dong Guo, Yu Li

    Background Recent research showed that probiotics treatment may reduce insulin resistance, regulate lipid metabolism, raise liver enzyme levels, and ameliorate inflammation in individuals with non-alcoholic fatty liver disease (NAFLD). However, the association between probiotic use and hepatic steatosis in people has not been identified. The purpose of this study was to investigate the possible relationship between probiotic exposure and hepatic steatosis.Methods The cross-sectional research was conducted among adults with complete data on probiotic exposure and hepatic steatosis in the 2011–2016 National Health and Nutrition Examination Survey (NHANES). Probiotic exposure was assessed using a dietary supplement questionnaire. Hepatic steatosis was evaluated with hepatic steatosis index (HSI). Weighted multivariable regression analysis, subgroup analysis, and interaction analysis were conducted to explore the independent relationship between probiotic exposure and hepatic steatosis. The restricted cubic spline (RCS) was used to analyze the curve association between yogurt and hepatic steatosis.Results A total of 7891 participants were included in the study represented 146.7 million non-institutionalized residents of the United States, of whom 4322 (54.77%) were diagnosed with hepatic steatosis. Multivariable logistic regression showed probiotic exposure had significantly inverse associations for hepatic steatosis (OR = 0.84, 95% CI: 0.72–0.97, P = 0.02) after adjusting for all covariates. Once more, the independent relationship between probiotic exposure and hepatic steatosis was verified by subgroup analysis and interaction analysis. The restricted cubic spline model demonstrated a robust J-shaped link between yogurt and hepatic steatosis, revealing a significant decrease in risk within the lower range of yogurt, which attained the lowest risk close to 0.4 cup.Conclusions These results suggested that probiotic exposure may have beneficial effects for hepatic steatosis, along with a J-shaped relationship between yogurt and hepatic steatosis. This study recommends that people take half a cup of yogurt daily. Further research is required to identify the mechanistic relationships between probiotics exposure and hepatic steatosis.

  • Open Access

    Effect of operative positions during bariatric surgery on postoperative nausea and vomiting

    by Zhaopeng Li, Yancheng Song, Yaoyao Tian, Yali Li, Xiaojuan Yang, Xia Zhou, Zhao Li, Shuguang Liu, Yu Li

    Objective To explore the effect of operative positions during bariatric surgery on postoperative nausea and vomiting(PONV) .Methods The patients with obesity who underwent laparoscopic sleeve gastrectomy (LSG) in the hospital from June 2020 to February 2022 were divided into two groups and analyzed retrospectively. The multivariable logistic regression analyses and T test were used to study the influence for operative positions on PONV.Results There were 15 cases of PONV in the prone split-leg position group, with an incidence rate of 50%, and 11 cases of PONV in the supine position group, with an incidence rate of 36.7%(P = 0.297). The operation time in the prone split-leg position group was 168.23 ± 46.24 min and the anesthesia recovery time was 55.03 ± 21.392 min. The operation time in the supine position was 140.60 ± 32.256 min and the anesthesia recovery time was 44.60 ± 13.307 min. There were significant differences between the two groups(P༜0.05). Multivariable analysis showed that the operative positions was not an independent risk factor for PONV, with an OR of 1.192 ( 95%CI: 0.376–3.778, P = 0.766).Conclusions This study showed that the operative positions may affect the PONV. Although, the difference in the incidence of PONV was not significant. The operative positions should be carefully selected for the patients with obesity before surgery.

  • Open Access

    Associations between Probiotic Exposure and Hepatic Steatosis: A nationwide cross-sectional study

    by Yancheng Song, Wencong Guo, Junke Wang, Shuguang Liu, Zhaopeng Li, Zhao Li, Dong Guo, Yu Li

    Background: Recent research showed that probiotics treatment may reduce insulin resistance, regulate lipid metabolism, raise liver enzyme levels, and ameliorate inflammation in individuals with non-alcoholic fatty liver disease (NAFLD). However, the association between probiotic use and hepatic steatosis in people has not been identified. The purpose of this study was to investigate the possible relationship between probiotic exposure and hepatic steatosis. Methods: The cross-sectional research was conducted among adults with complete data on probiotic exposure and hepatic steatosis in the 2011-2016 National Health and Nutrition Examination Survey (NHANES). Probiotic exposure was assessed using a dietary supplement questionnaire. Hepatic steatosis was evaluated with hepatic steatosis index (HSI). Weighted multivariable regression analysis, subgroup analysis, and interaction analysis were conducted to explore the independent relationship between probiotic exposure and hepatic steatosis. The restricted cubic spline (RCS) was used to analyze the curve association between yogurt and hepatic steatosis. Results:A total of 7891 participants were included in the study represented 146.7 million non-institutionalized residents of the United States, of whom 4322 (54.77%) were diagnosed with hepatic steatosis. Multivariable logistic regression showed probiotic exposure had significantly inverse associations for hepatic steatosis (OR = 0.84, 95% CI: 0.72–0.97, P=0.02) after adjusting for all covariates. Once more, the independent relationship between probiotic exposure and hepatic steatosis was verified by subgroup analysis and interaction analysis. The restricted cubic spline model demonstrated a robust J-shaped link between yogurt and hepatic steatosis, revealing a significant decrease in risk within the lower range of yogurt, which attained the lowest risk close to 0.4 cup. Conclusions: These results suggested that probiotic exposure may have beneficial effects for hepatic steatosis, along with a J-shaped relationship between yogurt and hepatic steatosis. This study recommends that adults take half a cup of yogurt daily. Further research is required to identify the mechanistic relationships between probiotics exposure and hepatic steatosis.

  • Open Access

    Systemic immune-inflammation index is associated with hepatic steatosis: Evidence from NHANES 2015-2018

    by Yancheng Song, Wencong Guo, Zhaopeng Li, Dong Guo, Zhao Li, Yu Li

    Background: As a novel inflammatory marker, Systemic Immune-Inflammation Index (SII) has not been studied with hepatic steatosis. The aim of this study was to investigate the possible relationship between SII and hepatic steatosis.Methods: In the cross-sectional investigation, adults having complete information on SII, hepatic steatosis, and bariatric surgery from the 2015–2018 National Health and Nutrition Examination Survey (NHANES) were included. Hepatic steatosis was evaluated with heaptic steatosis index (HSI). The platelet count × neutrophil count/lymphocyte count was used to compute SII. We investigated the independent interaction between SII and hepatic steatosis using weighted multivariable regression analysis and subgroup analysis. To explore the potential relationship between SII, bariatric surgery and hepatic steatosis by controlling potential confounders by propensity score matching.Results: The study involved 10505 participants in total, 5937 (56.5%) of whom had hepatic steatosis according to the diagnosis. After adjusted for covariates, multivariable logistic regression revealed that high SII level was an independent risk factor for hepatic steatosis (OR = 1.30, 95% CI: 1.10-1.52, P 0.01). Unexpectedly, bariatric surgery reduced SII even after PSM corrected for differences of BMI and HSI.Conclusions: In US adults, SII was positively correlated with an increase in hepatic steatosis. The SII may be a simple and affordable way to identify hepatic steatosis. Bariatric surgery may reduce SII without resorting to weight loss. This needs to be verified in additional prospective research.


  • Effects of Racial Differences on Bariatric Surgery Selection

    by Yancheng Song, Wencong Guo, Yu Li